I'm sure everyone has seen that acquisition of Anterios by Allergan. Anterios was developing a topical Botox (ANT1207) and researching it for Axillary HH. I inquired with Allergan recently as to whether there were any studies being conducted for palmar/plantar HH as well, and of course received the standard response that they could not provide any information. I'm not sure if there have been any studies conducted but I did bring this topic up to my dermatologist a year or two ago and he said that yes studies were being conducted. Has anyone else heard this or does anyone have any more info? I think this could be an excellent option as it is a topical application that would last for several months at a time.